IL Monthly Puff: Medical Opt-In Opens, Drive-Thru Debuts, Outdoor Grow Proposed
September 2026 brings a stack of structural changes to Illinois retail. The Illinois cannabis medical license opt-in window opened today, letting adult-use dispensaries add medical sales at a lower tax rate. Grayville just got the state’s first dual-window drive-thru, regulators proposed allowing outdoor cultivation for extraction, and a federal class action landed against three of the state’s largest companies over medical marketing claims.
Top Headlines This Month
- Adult-use dispensaries can now apply for medical sales license
- Federal class action targets Cresco, GTI, and Verano
- Terrabis opens Illinois first dual-window drive-thru in Grayville
- Regulators propose outdoor cultivation for extraction products
Illinois: Adult-Use Dispensaries Can Now Apply for Medical Sales License
The Illinois Department of Financial and Professional Regulation opened its application window today, September 10, 2026, for adult-use dispensaries to add medical cannabis sales. The authority comes from Public Act 104-0463 (SB 3222), signed by Governor JB Pritzker on June 12, 2026. Any adult-use dispensary holding an active license in good standing is eligible to apply for what the industry calls the 15-37 license, named after the section of the bill that created it. The five-page application requires a floor plan showing a dedicated medical consultation area, zoning documentation, a patient-prioritization plan, compliance attestations, and a $5,000 fee. Applications must be submitted at least 30 days before the dispensary’s planned implementation date. Opted-in dispensaries may sell to registered medical patients at the medical tax rate rather than the adult-use rate, up to each patient’s allotment. All applications go to IDFPR specifically, not IDPH which administers the patient registry separately. The license creates a dual-rate tax structure inside a single retail location, giving dispensaries a formal path to serve registered patients at a lower tax rate while maintaining adult-use sales for everyone else. The statute is enacted and the application form is published, so the legal framework is settled. What is not yet established is how IDFPR reviews floor plans and what documentation satisfies the zoning requirement in practice, since no dispensary has completed the process. The first cohort of applicants will set that standard.
Federal: Class Action Targets Illinois Cannabis Companies Over Medical Marketing Claims
A federal class action lawsuit, Murray, et al. v. Cresco Labs Inc., et al., No. 3:26-cv-50184, was filed May 4, 2026 in the U.S. District Court for the Northern District of Illinois, naming three Illinois-based cannabis companies: Cresco Labs Inc., Green Thumb Industries Inc., and Verano Holdings Corp. The complaint includes forty-one putative class representatives from twelve states. The plaintiffs allege the defendants ran a concerted campaign to convince the public that recreational cannabis products are medicine whose use confers health benefits those products do not confer. The alleged misrepresentations include therapeutic claims for PTSD, migraines, chronic pain, and inflammation, disseminated through websites, blogs, social media channels, and literature, with no relevant warnings on product labels. The plaintiffs also allege defendants created pseudo-research identifying purported health benefits. The defendants have moved to stay discovery pending rulings on motions to dismiss, and plaintiffs filed the August 24 memorandum asking the court to deny the stay or permit limited discovery. The lawsuit arrived alongside the federal government’s April 2026 rescheduling of medical marijuana to Schedule III, which brought economic benefits to state-licensed companies including Section 280E tax relief. The case puts marketing language about therapeutic benefits under federal scrutiny across a twelve-state class, and the outcome of the pending motions to dismiss will determine whether the litigation proceeds into discovery and broader exposure for the named defendants.
Grayville: Terrabis Opens What It Calls Illinois First Dual-Window Drive-Thru Dispensary
Terrabis opened what it describes as the first dispensary drive-thru in Illinois to feature two windows, at its Grayville location at 105 Koehler St., directly off I-64 near the Indiana border. The opening follows the passage of Senate Bill 3222, which authorized Illinois dispensaries to offer drive-thru and curbside pickup. The dual-window design allows the location to serve two vehicles at once. The Grayville dispensary operates from 6 a.m. to midnight Sunday and Monday, and from 6 a.m. to 2 a.m. Tuesday through Saturday. Customers place and pay for orders online and present a valid ID at the window. The full product menu includes flower, pre-rolls, edibles, vapes, and concentrates. Terrabis, a privately held multi-state company with dispensaries in Illinois and Missouri and a corporate office in Chicago, opened two of Missouri’s earliest drive-thru dispensaries in O’Fallon and Springfield in 2021 and expanded its O’Fallon location to 24-hour operations earlier in 2026. The Grayville location is the first concrete example of the drive-thru retail format made possible by Senate Bill 3222. The dual-window setup and extended late-night hours reflect a format built around speed and accessibility for both local customers and travelers along I-64.
Illinois: Regulators Propose Outdoor Cultivation for Licensed Cannabis Producers
The Illinois Department of Agriculture has proposed a rule change that would allow licensed cannabis companies and craft growers to cultivate cannabis outdoors, reversing the agency’s previous interpretation that state law prohibited it. Under the proposal, outdoor growing areas must be fully enclosed by a continuous chain-link fence at least 8 feet high, topped with razor wire or security wire, and screened from public view. Outdoor-grown cannabis would be permitted only for extraction purposes, meaning concentrates for edibles, vapes, and oils, but not flower for smoking. The shift follows court wins by at least two companies, Green Thumb Industries and Nature’s Grace and Wellness, which secured rulings allowing outdoor grows in screened structures, and a subsequent lawsuit filed by Curaleaf Holdings through its subsidiary Compass Ventures, Inc. seeking the same. The proposed rule is now in a 45-day public comment period before it can become final. Home growers are not included in the change; registered medical patients remain limited to growing up to five plants indoors. The proposal has particular weight for craft growers. The founder of the Illinois Independent Craft Growers Association described it as a game changer for small growers, noting that only a fraction of licensed craft growers have been cleared to open due to high start-up costs and financing difficulty. Researchers estimate outdoor cultivation could significantly reduce the environmental impact compared to indoor cultivation, which would reduce production costs and could lower consumer prices. The Cannabis Business Association of Illinois, which represents most of the largest growers and dispensaries in the state, said it would survey members before submitting comments, acknowledging that cheaper outdoor production raises real questions for those who have already invested heavily in indoor facilities.
Seeking Illinois Cannabis Licenses
For Buyers
- $1.25M total consideration
- $200K at signing of definitive documents
- $50K on state approval of the transfer
- $1M carried over 36 months once the store opens
- Buyer can collateralize the carry
For Sellers
- Operational retail in Illinois
- Operational manufacturing licenses, or paper licenses
The Bottom Line
September 2026 reshapes the Illinois cannabis market on four fronts at once: a medical sales opt-in for adult-use dispensaries, a new drive-thru retail format live in Grayville, a proposed outdoor cultivation rule with real cost implications for craft growers, and a federal class action putting marketing language under scrutiny. The Illinois cannabis medical license framework is settled in statute, but the first cohort of applicants and the pending federal motions will define how the month’s changes play out.
📬 Get Monthly Market Updates
Stay ahead of the curve with our monthly cannabis retail market newsletter. New markets, regulatory changes, and expansion opportunities delivered to your inbox.
